Health Products

APO-Candesartan / HCTZ Product Recall (2015-05-19)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
KP0050B. APO-Candesartan / HCTZ 25 mg
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
TabletDIN 02395134Candesartan Cilexetil 32 mg
KN9456A. APO-Candesartan / HCTZ 12.5 mg
Recalling Firm
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
Marketing Authorization Holder
Apotex Inc.
150 Signet Drive
Toronto
M9L 1T9
Ontario
CANADA
TabletDIN 02395126Candesartan Cilexetil 32 mg

Introduction

Recalled products
  1. APO-Candesartan / HCTZ 12.5 mg
  2. APO-Candesartan / HCTZ 25 mg

Reason

Product lots KN9456, KP0842, KV0887, KP0050 did not meet the shelf life specification for CAD II impurity.

Product lots KN9458, KN9461, KV7989, KV0896 obtained results that were close to the specification limit for CAD II impurity (out of trend).

Product lot KV0886 did not meet the shelf life specification for CAD II impurity (result: 0.6%, limit: NMT 0.5%) during stability testing at 9 month time point.

Depth of distribution

Wholesalers

Related alerts

Apotex Product Recall (2015-04-10)
2015-04-10 | Drugs
Type of communication: Recall

APO-Candesartan 16 mg (2015-05-01)
2015-05-01 | Drugs
Type of communication: Recall

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime